[The pharmacological and clinical outlook for mibefradil--a new selective T-type calcium channel antagonist].
Eliseev
O M
OM
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D020748:Mibefradil; D016032:Randomized Controlled Trials as Topic; D013764:Tetrahydronaphthalenes / Q000494:pharmacology* / Q000627:therapeutic use*
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil
Farmakologicheskie i klinicheskie perspektivy mibefradila--novogo selektivnogo antagonista kal'tsievykh kanalov tipa T.